Françoise Grudé
Françoise Grudé publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics, on topics such as Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology and Gastric Cancer Management and Outcomes.
- World rank
- #6,840,590 of 7,710,434 ranked researchers
- Rank in France
- #291,743 of 324,115
- Works
- 68
- Citations
- 233
- Citations per work
- 3.4
What does Françoise Grudé research?
Françoise Grudé's work is mostly in Medicine (53%), Economics, Econometrics and Finance (10%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3856.3%
- Medicine3653.2%
- Health Professions23.1%
- Everything else1826.6%
- Social Sciences710.4%
- Life Sciences56.7%
- 1Oncology42% of their works
- 2Pulmonary and Respiratory Medicine12% of their works
- 3Economics and Econometrics10% of their works
- 4Cancer Research4% of their works
- 5Molecular Biology3% of their works
- 6General Health Professions3% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Gastric Cancer Management and Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Neutropenia and Cancer Infections
- Cancer Immunotherapy and Biomarkers
- Economic and Financial Impacts of Cancer
- Cancer Genomics and Diagnostics
Which keywords describe Françoise Grudé's research?
The keywords of their largest research topics: Chemotherapy, Quality of Life, Cetuximab, KRAS Mutations, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Endoscopic Resection and Gastric Cancer.
- Mutational Signatures
- PD-1 and PD-L1
- Financial Toxicity
- Febrile Neutropenia
- Health Utility Measures
- Gastric Cancer
- Taxanes
- KRAS Mutations
- Quality of Life
- Chemotherapy
- Cetuximab
- Chemotherapy-Induced Peripheral Neuropathy
- Endoscopic Resection
- Cost-effectiveness Analysis
- Antimicrobial Agents
- Cost of Care
- Immune Checkpoint Blockade
- Cancer Genomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Chemotherapy433 topics
- Quality of Life312 topics
- Cetuximab251 topic
- KRAS Mutations251 topic
- Chemotherapy-Induced Peripheral Neuropathy221 topic
- Taxanes221 topic
- Endoscopic Resection101 topic
- Gastric Cancer101 topic
- Cost-effectiveness Analysis91 topic
- Health Utility Measures91 topic
- Antimicrobial Agents81 topic
- Febrile Neutropenia81 topic
- Cost of Care71 topic
- Financial Toxicity71 topic
- Immune Checkpoint Blockade71 topic
- PD-1 and PD-L171 topic
- Cancer Genomics51 topic
- Mutational Signatures51 topic
Where does Françoise Grudé work?
Françoise Grudé's main affiliation in the publication record is Université Bretagne Loire, France.
How many publications and citations does Françoise Grudé have?
OpenAlex counts 68 works and 233 citations for Françoise Grudé, an h-index of 9, ranking #6,840,590 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Françoise Grudé. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.